The Role of Glutamate Dehydrogenase 1 in Congenital Obstructive
Nephropathy: Insights from Neonatal Rodent Models and Implications
for Veterinary Medicine
1Department
of Pediatric Urology, Shengjing Hospital of China Medical
University, Shenyang, Liaoning 110004, China; 2Key
Laboratory of Health Ministry for Congenital Malformation, Shengjing
Hospital of China Medical University, Shenyang 117004, China; 3Department
of Gastric Surgery, Liaoning Cancer Hospital & Institute (Cancer
Hospital of Dalian University of Technology), Shenyang 110042,
China; 4Department of Pediatric Urology, Guangzhou Women
and Children's Medical Center, Guangzhou Medical University,
Guangzhou 510623, Guangdong, China; 5Department of
Urology, Wuhan Children’s Hospital (Wuhan Maternal and Child
Healthcare Hospital), Tongji Medical College, Huazhong University of
Science and Technology, Wuhan 430016, China;
6Department
of Laboratory Animal Science, China Medical University, Shenyang
110122, China; 7College of Animal Science and Veterinary
Medicine, Shenyang Agricultural University, Shenyang110866, China;
8Research
Center for Swine Diseases, College of Veterinary Medicine, Sichuan
Agricultural University,Chengdu 611130, China.
Congenital obstructive nephropathy (CON) refers to kidney damage caused by
impaired urine flow due to congenital malformations of the urinary tract. CON is
a leading cause of chronic kidney disease (CKD) in young animals, particularly
in dogs and cattle, characterized by congenital urinary tract
obstruction-induced renal tissue inflammation, fibrosis, and progressive
parenchymal damage. It represents a significant clinical challenge in veterinary
medicine due to the lack of effective therapeutic options. Glutamate
dehydrogenase 1 (GDH1), a key mitochondrial enzyme regulating amino acid
metabolism, energy homeostasis, and redox balance, is linked to renal fibrosis
via Reactive Oxygen Species (ROS) and profibrotic pathways, making it a
plausible target for CON, while the role of GDH1 in animals with CON remains
unclear. This study evaluates the role of GDH1 in obstructive renal injury via
in vivo and in vitro models. The function of GDH1 was investigated in a neonatal
rat model of partial unilateral ureteral obstruction (PUUO) and the potential
mechanism was explored in an in vitro model. GDH1 expression was reduced
in a neonatal rat model of PUUO. GDH1 overexpression alleviated renal fibrosis
in PUUO-operated rats. TGF-β1-treated rat renal tubular epithelial cells
(NRK-52E) were employed as an in vitro model. Besides, GDH1
overexpression conferred protection against TGF-β1-induced cellular damage,
which was mediated by enhanced cell survival, reduced apoptosis, as well as the
suppression of pro-fibrotic marker expression. In conclusion, our study confirms
GDH1-mediated protection conferring resistance against CON, highlighting GDH1 as
a promising therapeutic target.
To Cite This Article:
Wang R, Zhao Q, Fan X, Gao X, Zhang J, Yu X,
Zhou S, Liu J,
Liu D, Gao X, You J, Liu X and YangY,
2025. The role of glutamate dehydrogenase 1 in congenital obstructive
nephropathy: insights from neonatal rodent models and implications for
veterinary medicine.
Pak Vet J, 45(4): 2074-2080. http://dx.doi.org/10.29261/pakvetj/2025.xxx